Jerome D. Jabbour - 26 Feb 2026 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: Director
Issuer ticker: INDP
Reported as of: 26 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Feb 2026, 16:06:16 UTC
Prior SEC filing: 02 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Jerome Jabbour

Key filing fact

Jerome D. Jabbour filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 27 Feb 2026.

Key facts

This page summarizes Jerome D. Jabbour's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Feb 2026, 16:06.

Change

Previous filing in this sequence was filed on 02 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698838 Primary reporting owner

Jabbour Jerome D

Relationship: Director
Address: C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature: /s/ Jerome Jabbour
Signature date: 27 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INDP transaction Derivative

Option to Buy Common Stock

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 26 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $2.06
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Issuer's board of directors through each vesting date.